Stock analysis, trade plans, and proprietary indicators by Trend Edge.
About TG Therapeutics Inc
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and activ… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: December 14, 1995
Headquarters: 3020 Carrington Mill Blvd., Morrisville, NC, United States, 27560
Founder-Led: Yes — Michael Sean Weiss (Chairman, President, and Chief Executive Officer)
Key Metrics
Current Price
$39.73
Market Cap
$6.01B
Float
135.1M
Shares Outstanding
153.1M
P/E (Forward)
30.21
P/E (TTM)
13.72
Price/Sales (TTM)
8.58
vs. Analyst Target
+20.8% to analyst PT
Profit Margin
65.95%
Operating Margin (TTM)
16.98%
Revenue (TTM)
$700M
Earnings Growth (YoY)
300.00%
Dividend Rate
None
Analyst Target Price
$48.00 (7 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$152,000
-$279M
$152,000
-$273M
2021
$6.7M
-$348M
$5.9M
-$342M
2022
$2.8M
-$224M
$2.5M
-$213M
2023
$234M
$12.7M
$220M
$26.1M
2024
$329M
$23.4M
$291M
$49.9M
2025
$616M
$447M
$516M
$134M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
$141M
$28.2M
Sep 2025
$162M
$391M
Dec 2025
$193M
$23.0M
Mar 2026
$205M
$19.8M
Ownership & Float
Insider Ownership
7.5%
Institutional Ownership
70.3%
Short Float
20.0%
% of All Funds Holding
4.06%
Number of Funds Holding
334
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$36.58
Near-term / short-term trend
Weekly
40-Week SMA
$32.65
Medium-term trend
Weekly
80-Week SMA
$33.71
Cyclical trend (business cycle)
Weekly
200-Week SMA
$22.95
Secular trend (multi-year)
Monthly
10-Month SMA
$32.96
Near-term monthly trend
Monthly
20-Month SMA
$33.64
Medium-term monthly trend
Monthly
40-Month SMA
$25.51
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$29.40
support
1.17x
1 months ago
$25.30
support
1.21x
17 months ago
Historical Earnings Reactions (64 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-0.27%
0.00%
45.31%
18.18%
-26.67%
1 Day
-1.64%
-0.62%
37.50%
17.91%
-33.33%
1 Week
-0.99%
-2.16%
42.19%
55.22%
-32.00%
2 Weeks
-2.02%
-0.80%
42.19%
30.60%
-47.19%
1 Month
-0.02%
-2.04%
46.03%
99.79%
-52.00%
Next earnings: July 25, 2026 (58 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
20.8%
56.3%
16
Feb
15.2%
68.8%
16
Mar
8.2%
62.5%
16
Apr
1.6%
43.8%
16
May
0.4%
53.3%
15
Jun
-1.0%
43.8%
16
Jul
-1.0%
31.3%
16
Aug
-9.1%
43.8%
16
Sep
-7.0%
31.3%
16
Oct
-9.2%
25.0%
16
Nov
12.8%
68.8%
16
Dec
7.6%
43.8%
16
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.74%
42.8%
755
Tuesday
0.12%
43.6%
831
Wednesday
0.46%
47.1%
828
Thursday
0.75%
42.9%
813
Friday
0.01%
42.7%
812
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 70.3%
Insider Transactions — Smart Summary
Total insider ownership: 7.5%
Founder-led management: Michael Sean Weiss (Chairman, President, and Chief Executive Officer)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for TG Therapeutics Inc
(TGTX) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.